NASDAQ:BCPCBalchem Stock Price, Forecast & News

Balchem's stock was trading at $89.29 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, BCPC shares have increased by 15.1% and is now trading at $102.76.
View which stocks have been most impacted by COVID-19.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Balchem in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Balchem.

Balchem is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020.
View our earnings forecast for Balchem.

Balchem Co. (NASDAQ:BCPC) posted its earnings results on Friday, July, 31st. The basic materials company reported $0.85 EPS for the quarter, topping the Zacks' consensus estimate of $0.55 by $0.30. The basic materials company earned $173.36 million during the quarter, compared to analysts' expectations of $161.35 million. Balchem had a net margin of 12.18% and a return on equity of 14.32%. Balchem's quarterly revenue was up 7.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.77 earnings per share.
View Balchem's earnings history.

Balchem declared an annual dividend on Wednesday, December 18th. Stockholders of record on Monday, December 30th will be given a dividend of $0.52 per share on Friday, January 17th. This represents a dividend yield of 0.51%. The ex-dividend date is Friday, December 27th. This is an increase from Balchem's previous annual dividend of $0.47.
View Balchem's dividend history.

2 analysts have issued 1 year target prices for Balchem's stock. Their forecasts range from $100.00 to $126.00. On average, they expect Balchem's share price to reach $113.00 in the next twelve months. This suggests a possible upside of 10.0% from the stock's current price.
View analysts' price targets for Balchem.

News coverage about BCPC stock has trended very negative recently, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Balchem earned a coverage optimism score of -3.2 on InfoTrie's scale. They also gave news stories about the basic materials company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the near future.
View the latest news about Balchem.

Balchem saw a decline in short interest during the month of July. As of July 31st, there was short interest totaling 433,300 shares, a decline of 12.4% from the July 15th total of 494,500 shares. Based on an average trading volume of 167,300 shares, the short-interest ratio is currently 2.6 days. Currently, 1.4% of the shares of the company are sold short.
View Balchem's Short Interest.

Some companies that are related to Balchem include Sherwin-Williams (SHW), Ecolab (ECL), International Flavors & Fragrances (IFF), Celanese (CE), RPM International (RPM), Albemarle (ALB), Ashland Global (ASH), NewMarket (NEU), Quaker Chemical (KWR), W. R. Grace & Co (GRA), Stepan (SCL), HB Fuller (FUL), PolyOne (POL), Sensient Technologies (SXT) and Innospec (IOSP).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Balchem investors own include Ecolab (ECL), AbbVie (ABBV), CVS Health (CVS), IBM (IBM), Lowe's Companies (LOW), AT&T (T), Enterprise Products Partners (EPD), Mcdonald's (MCD), Altria Group (MO) and Merck & Co., Inc. (MRK).

Balchem trades on the NASDAQ under the ticker symbol "BCPC."

Balchem's stock is owned by a variety of retail and institutional investors. Top institutional investors include Conestoga Capital Advisors LLC (2.75%), Wasatch Advisors Inc. (2.58%), Macquarie Group Ltd. (1.79%), FMR LLC (1.26%), Bank of New York Mellon Corp (1.16%) and GW&K Investment Management LLC (1.12%). Company insiders that own Balchem stock include Daniel E Knutson, David F Ludwig and Scott C Mason.
View institutional ownership trends for Balchem.

BCPC stock was sold by a variety of institutional investors in the last quarter, including Wasatch Advisors Inc., New York State Common Retirement Fund, ProShare Advisors LLC, Moody Aldrich Partners LLC, Prudential Financial Inc., Principal Financial Group Inc., State of Tennessee Treasury Department, and PNC Financial Services Group Inc..
View insider buying and selling activity for Balchem.

BCPC stock was purchased by a variety of institutional investors in the last quarter, including FMR LLC, Assenagon Asset Management S.A., Bank of Montreal Can, State of Wisconsin Investment Board, Conestoga Capital Advisors LLC, Macquarie Group Ltd., GW&K Investment Management LLC, and First Trust Advisors LP. Company insiders that have bought Balchem stock in the last two years include Daniel E Knutson, and Scott C Mason.
View insider buying and selling activity for Balchem.

Shares of BCPC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of BCPC stock can currently be purchased for approximately $102.76.

Balchem has a market capitalization of $3.32 billion and generates $643.71 million in revenue each year. The basic materials company earns $79.67 million in net income (profit) each year or $3.19 on an earnings per share basis. Balchem employs 1,424 workers across the globe.

The official website for Balchem is www.balchem.com.

Balchem's mailing address is 52 Sunrise Park Road, NEW HAMPTON NY, 10958. The basic materials company can be reached via phone at 845-326-5600 or via email at [email protected]